Press Release - New data from the PURPOSE 2 study of twice-yearly lenacapavir for HIV prevention are among the scientific highlights at HIVR4P 2024, the 5th HIV Research for Prevention Conference, ...
Some results have been hidden because they may be inaccessible to you